Apeiron Synthesis
Leading the way in metathesis.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD29—43m (Dealroom.co estimates Dec 2022.)
Company register number KRS0000455480
Wroclaw Lower Silesian Voivodeship (HQ)
Financials
Estimates*
EUR | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m | <1m |
% growth | - | (56 %) | 295 % | (72 %) | 531 % |
EBITDA | (<1m) | <1m | (<1m) | <1m | <1m |
% EBITDA margin | (90 %) | 237 % | (68 %) | 247 % | 13 % |
Profit | (<1m) | <1m | (<1m) | <1m | (<1m) |
% profit margin | (101 %) | 149 % | (110 %) | 41 % | (20 %) |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | - | ||
* | €4.8m | Late VC | |
Total Funding | CAD7.2m |
Related Content
Recent News about Apeiron Synthesis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.